About the Product

Description


Vecotime 4 Injection contains Vecuronium 4mg, a neuromuscular blocking agent used for muscle relaxation during surgical procedures, mechanical ventilation, and intensive care treatments. It ensures controlled muscle paralysis and optimal surgical conditions.

Vecuronium works by blocking acetylcholine at the neuromuscular junction, causing temporary skeletal muscle relaxation without affecting consciousness. Its intermediate duration of action allows precise control during anaesthesia.

This injection is commonly prescribed in general surgeries, ICU ventilation management, and other procedures requiring controlled muscle relaxation. Its intravenous form provides rapid onset and reliable efficacy under medical supervision.

For PCD pharma franchise partners, Vecotime 4 Injection is a high-value hospital and critical care product, available at the best price for PCD pharma franchise. Its consistent demand in operative and critical care settings, along with prescriber trust, makes it an essential addition to any injectable or anaesthesia medicine portfolio.

Common side effects may include mild nausea, headache, or gastrointestinal discomfort. Rarely, patients may experience allergic reactions such as rash, itching, or swelling. If severe symptoms occur, medical advice should be sought immediately.

Troxipot 300 Tablet is indicated for the treatment of gastritis, gastric and duodenal ulcers, dyspepsia, and other conditions associated with excessive gastric acid secretion or mucosal irritation, as prescribed by a healthcare professional.

Troxipot 300 Tablet should be taken exactly as prescribed, preferably after meals. Patients should avoid alcohol and foods that may irritate the stomach. Inform your doctor if you have liver or kidney issues or if symptoms persist despite treatment.

Store Troxipot 300 Tablet in a cool, dry place away from direct sunlight and moisture. Keep the tablets in their original packaging and out of reach of children. Do not use after the expiry date mentioned on the pack.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Vecuronium 4mg Injection in the PCD pharma franchise market?

Vecuronium 4mg Injection has demand in the hospital care, critical care, anesthesia, and surgical care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on institutional and specialty healthcare portfolios.

Why should medical distributors include Vecuronium 4mg Injection in their product range?

Medical distributors and agencies can benefit from consistent demand for anesthesia and critical care support under specialist medical supervision. Vecuronium 4mg is a non-depolarizing neuromuscular blocking agent used during surgical and critical care procedures Commonly administered to facilitate endotracheal intubation and provide skeletal muscle relaxation during surgery as directed by qualified anesthesiologists May also be used in intensive care settings where controlled muscle relaxation is required Injectable formulation is suitable for hospital, operation theatre, and critical care use Primarily utilized in surgical centers, multi-specialty hospitals, and intensive care units (ICUs) Widely used by anesthesiologists, intensivists, and critical care specialists This strengthens a comprehensive anesthesia and critical care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Vecuronium 4mg Injection with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from institutional demand, hospital procurement opportunities, reliable supply chain support, repeat orders from healthcare facilities, and attractive margins in the critical care segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.